GlassScriptPhysician profile
Karma Albert Schmidt
NPI 1548842545
$1,081.39
in general payments reported to CMS, 2019-2025
11 companies · $167 in 2025
The $167 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.34 · 2022: $201 · 2023: $596 · 2024: $98.94 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $259.75 | 2022-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $202.12 | 2023 | Lifevest |
| Daiichi Sankyo INC. | $124.99 | 2023 | Injectafer |
| Medtronic, INC. | $115.54 | 2024-2025 | Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $92.04 | 2025 | |
| Amgen INC. | $80.28 | 2021-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $75.58 | 2022 | |
| Merck Sharp & Dohme LLC | $49.56 | 2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $37.13 | 2023-2025 | Camzyos |
| Kiniksa Pharmaceuticals, LTD. | $27.25 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $17.15 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karma Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.